NewsBenzingaArdent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est Benzinga 2026.11.04 21:58 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3